Celltech Group (NYSE: CLL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celltech Group (NYSE: CLL)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Nealon who started this subject	5/30/2003 6:58:02 AM
From: nigel bates	Read Replies (1) of 123

Capital Group bought another 1% since Wednesday's announcement (they now hold 11.3%). Wednesday May 28, 2:09 pm ET WASHINGTON -(Dow Jones)- Capital Group International Inc. increased its holdings in Celltech Group PLC to 10.3%, according to an amended Schedule 13G filed Wednesday with the Securities and Exchange Commission (News - Websites). On Friday, Capital Group International beneficially owned 28.6 million Celltech Group ordinary shares, according to the filing. Previously, Capital Group International reported owning 19.2 million Celltech Group ordinary shares for a 7% stake on Dec. 31, 2002, according to a Feb. 14 filing. A Schedule 13G denotes a passive investment stake in a company. Filers aren't required to provide a reason for any changes in stake and aren't required to detail any transactions...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next